News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/CMLcells_Difu_Wu_230-v2.jpg)
Health Canada approves two tests for CML patients
- Author:
- HT Staff
Health Canada has approved the use of two tests designed to detect BCR-ABL transcripts in patients with chronic myeloid leukemia (CML)—the MRDx®...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/malaria_vaccine_Credit_Caitlin_Kleiboer_230_v2.jpg)
Markers associated with efficacy of malaria vaccine
- Author:
- HT Staff
New research has revealed markers associated with efficacy of the RTS,S/AS01E malaria vaccine (Mosquirix™). The study suggests malaria protection...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/Fatmouse-175.jpg)
Diet change can improve survival in obese mice with ALL
- Author:
- HT Staff
Switching to a low-fat diet can improve survival in obese mice with acute lymphoblastic leukemia (ALL), according to new research. Diet-induced...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/blood_samples_Credit_Graham_Colm_230.jpg)
FDA clears instrument for blood typing, screening
- Author:
- HT Staff
The U.S.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/Zhang_Chengcheng-Alex_PhD_UT-Southwestern-Medical-Center.jpg)
‘Compelling’ new target found for monocytic AML
- Author:
- HT Staff
Efforts to determine why immune checkpoint blockade is not successful in treating leukemia have resulted in a “compelling” new target to treat...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/multiple_myeloma_bone_marrow_aspirate_showing_230.jpg)
Triplet improves PFS in relapsed/refractory MM
- Author:
- HT Staff
Adding elotuzumab to pomalidomide and low-dose dexamethasone can improve progression-free survival (PFS) in patients with relapsed/refractory...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/multiplemyeloma.jpg)
CAR T therapy for MM receives RMAT designation
- Author:
- HT Staff
P-BCMA-101, an autologous chimeric antigen receptor (CAR) T-cell therapy being developed to treat patients with relapsed/refractory multiple...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/lab_mouse_on_foil_240.jpg)
Vaccine inhibits thrombus formation in mice
- Author:
- HT Staff
Investigators designed an antiplatelet vaccine they say could be a novel therapy to prevent recurrent ischemic stroke. The vaccine inhibits...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/eltrombopag-promata-GSK-230.jpg)
Combo worsens platelet recovery in MDS
- Author:
- HT Staff
Results from the phase 3 SUPPORT trial suggest there is no role for the combination of eltrombopag and azacitidine in patients with intermediate-...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/PDI-binding_theoretical-image_Dr.-Reeder-Robinson-of-MUSC-200.jpg)
Molecule enhances PI activity in multiple myeloma
- Author:
- HT Staff
Researchers say they have identified a new class of protein disulfide isomerase (PDI) inhibitors that sensitize multiple myeloma (MM) cells to...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/hemoscreen-200.jpg)
FDA clears portable hematology analyzer
- Author:
- HT Staff
The U.S.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/DLBCL.jpg)
Selinexor on fast track for DLBCL
- Author:
- HT Staff
The U.S.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/AML-paulo-henrique-orlandi-mourao-230.jpg)
Quizartinib receives accelerated assessment for AML
- Author:
- HT Staff
The European Medicines Agency has granted accelerated assessment to the marketing authorization application (MAA) for the FLT3 inhibitor...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/vials-syringe-240.png)
Sandoz won’t seek U.S. approval for rituximab biosimilar
- Author:
- HT Staff
Sandoz has decided not to pursue U.S. approval for its rituximab product (GP2013), a proposed biosimiliar of Rituxan/Mabthera. GP2013 (Rixathon,...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/myelofibrosis-primary-wiki-240.jpg)
CPI-0610 receives fast track designation for MF
- Author:
- HT Staff
The U.S.